Drug Facts
Composition & Profile
Identifiers & Packaging
PACKAGE/LABEL DISPLAY PANEL Code 4R3629 20 Units Fenwal Blood-Pack Unit Triple Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) For the Collection and Processing of 450 mL Blood Sample Diversion System, 16 ga. Ultra Thin Wall Fenwal HighFlo Needle Rx only Each unit consists of a primary container with 63 mL of CPDA-1 solution containing 2 g Dextrose (monohydrate) USP, 1.66 g Sodium Citrate (dihydrate) USP, 188 mg Citric Acid (anhydrous) USP, 140 mg Monobasic Sodium Phosphate (monohydrate) USP and 17.3 mg Adenine USP, pH may have been adjusted with sodium hydroxide; two empty 400 mL Transfer-Pack containers. Sterile , non-pyrogenic fluid path. See instructions for use. Single use only. Store at Controlled Room Temperature (refer to direction insert). Protect from freezing. Avoid excessive heat. • Open pouch by tearing across at notch. • Direct handling of product surfaces prior to extended storage in the foil pouch, may result in mold growth. • Unused units in open foil pouch may be kept up to 60 days by folding and securing open end of foil pouch to prevent possible loss of moisture, provided: I. Units are not removed from foil pouch, or II. Unused units removed from foil pouch are returned to the foil pouch within 12 hours. Units may be removed from the pouch and returned only once. • Units removed from the foil pouch (that are not returned to the pouch within 12 hours) must be used within 4 days (96 hours). Units out of the foil pouch for longer than 96 hours must be discarded. Manufacturer Fresenius Kabi AG 61346 Bad Homburg / Germany www.fresenius-kabi.com Made in US 47-28-13-527 REV: A 4r3629image4
- PACKAGE/LABEL DISPLAY PANEL Code 4R3629 20 Units Fenwal Blood-Pack Unit Triple Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) For the Collection and Processing of 450 mL Blood Sample Diversion System, 16 ga. Ultra Thin Wall Fenwal HighFlo Needle Rx only Each unit consists of a primary container with 63 mL of CPDA-1 solution containing 2 g Dextrose (monohydrate) USP, 1.66 g Sodium Citrate (dihydrate) USP, 188 mg Citric Acid (anhydrous) USP, 140 mg Monobasic Sodium Phosphate (monohydrate) USP and 17.3 mg Adenine USP, pH may have been adjusted with sodium hydroxide; two empty 400 mL Transfer-Pack containers. Sterile , non-pyrogenic fluid path. See instructions for use. Single use only. Store at Controlled Room Temperature (refer to direction insert). Protect from freezing. Avoid excessive heat. • Open pouch by tearing across at notch. • Direct handling of product surfaces prior to extended storage in the foil pouch, may result in mold growth. • Unused units in open foil pouch may be kept up to 60 days by folding and securing open end of foil pouch to prevent possible loss of moisture, provided: I. Units are not removed from foil pouch, or II. Unused units removed from foil pouch are returned to the foil pouch within 12 hours. Units may be removed from the pouch and returned only once. • Units removed from the foil pouch (that are not returned to the pouch within 12 hours) must be used within 4 days (96 hours). Units out of the foil pouch for longer than 96 hours must be discarded. Manufacturer Fresenius Kabi AG 61346 Bad Homburg / Germany www.fresenius-kabi.com Made in US 47-28-13-527 REV: A 4r3629image4
Overview
No description available yet.
Dosage & Administration
Not available
Warnings & Precautions
No warnings available yet.
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.